These mechanisms likely include leptin resistance, adipose tissue inflammation, and hepatic overproduction of VLDL, which have been implicated in both depression and hypertriglyceridemia (Grundy, 2004; Klop et al., 2013; Milaneschi et al., 2019). This evidence concerns the gene LEP and depressive symptom measurement.